In HCC cells, high concentration of FGF19 from autocrine, paracrine and endocrine secretion constitutively activates FGFR4, resulting in phosphorylation of GSK3β, which in favor of increased active β-catenin. The gene discussed is FGF19; the disease is hepatocellular carcinoma.